Form EFFECT Nasus Pharma Ltd
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 31, 2026 |
| Accession Number: | 0001493152-26-013287 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ISSA Show North America Introduces the Robotics & Autonomous Cleaning Experience at the 2026 Event
- Final State Budget Brings $5M for New Behavioral Health Pilot to Central Coast
- Group 1 Toyota West Bank Partners with United Cajun Navy for Storm Relief and Donation Drive
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
